Skip to content
Media, Medical Health Aged Care

Hiding in Plain Sight- Treatments for Parkinsons, Arthritis, Multiple Sclerosis, Diabetes and Cancer

Australian Apitherapy Association 2 mins read

A yellow symbol on a black backgroundDescription automatically generated

Australian Apitherapy Association   

12 June, 2024

Media Release

Hiding in Plain Sight- Treatments for Parkinson's, Arthritis, Multiple Sclerosis, Diabetes and Cancer

Possibly it's because bee products are so ancient, and so familiar to us, that we regard them as innocuous, but they are effectively hiding from us in plain sight while we continue to search for new and newer methods to treat diseases Western medicine regards as untreatable.

Research presented at the Asian Apiarists Association Conference in Perth today reveals that impressive research is happening in many countries that have included Apitherapy, bee medicine- in their national medical systems.

For example,  Professor Igor Krivopalov-Mosckvin, heading up the Russian Apitherapy Institute presents an impressive study of how 1600 Russian subjects had their Parkinson’s Disease symptoms reversed.

The International Apitherapy forum is being hosted as part of the 17th Asian Apiarists Association conference in Perth, Western Australia on June 12, 2024.

Other speakers also discussed how Apitherapy is used in many countries to tackle difficult to treat illnesses that western medicine struggles to manage.

This conference is a wonderful opportunity for Australians to hear about how Apitherapy is widely adopted in the medical systems of around 80 countries, though in Australia we hardly know about it,” said the President of the Australian Apitherapy Association, Dr Bridget Goodwin.”

Ïf you or someone in your family had Parkinson’s Disease, you would really want to know more about how this is being treated by Apitherapy in Russia, and how cancer, arthritis and multiple sclerosis are being treated using Apitherapy as part of the mainstream medical systems of China, Hungary, Romania, and Taiwan.”

Dr Goodwin will be speaking about the introduction of Apitherapy to Australia through the Australian Apitherapy Association and how international collaboration is helping Australians learn more about how these powerful medical treatments are being conducted around the world.

For more information contact Dr Bridget Goodwin 0477 509 247

infor@apitherapyaustralia.net

www.apitherapyaustralia.net

Media

More from this category

  • Medical Health Aged Care
  • 24/06/2024
  • 17:07
Takeda Pharmaceutical Company Limited

Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies

LIVTENCITY Is the First and Only Post-Transplant Anti-CMV Treatment Approved in Japan That Targets/Inhibits UL97 Protein Kinase1 CMV Is One of the Most Common…

  • Contains:
  • CharitiesAidWelfare, Medical Health Aged Care
  • 24/06/2024
  • 16:20
National Rural Health Alliance

Community-led innovation to revolutionise healthcare access in rural Australia

The National Rural Health Alliance (the Alliance) is delighted that the Minister for Health and Aged Care, the Hon Mark Butler, has today announced…

  • Contains:
  • Business Company News, Medical Health Aged Care
  • 24/06/2024
  • 12:25
Jane Morgan Management

Imugene (ASX:IMU) Doses First Patient in Pioneering Phase 1 onCARlytics Trial

Sydney, Australia, 24 June 2024: Imugene Limited (ASX: IMU), a clinical-stage immuno-oncology company, is thrilled to announce the dosing of the first patient in the intravenous (IV) infusion combination arm of its Phase 1 onCARlytics (CF33-CD19) clinical trial. This groundbreaking trial, named OASIS, is being conducted at City of Hope in California and is designed to transform the treatment landscape for patients with advanced solid tumors. The OASIS trial is a world-first, combining a CD19-expressing oncolytic virus with a CD19-targeting drug. The trial aims to recruit 40-45 patients with advanced solid cancers that have metastasized, with preliminary early combination data…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.